Skip to content

Sickle Cell Disease, Neurocognitive Disorders, Social Participation

Sickle Cell Disease, Neurocognitive Disorders, Social Participation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04793854
Acronym
SOCIODREP
Enrollment
134
Registered
2021-03-11
Start date
2018-09-19
Completion date
2019-06-03
Last updated
2021-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Disease

Keywords

neurocognitive disorders, social participation

Brief summary

This project will promote the development of transdisciplinary analyses. Neuropsychological disorders will be explored with the usual appropriate tests done by psychologists and neuropsychologists regularly involved in the management of sickle cell disease affected children. For the social sciences' component, various methods will be used: Measure of the Life habits (MHAVIE), Measure of Environmental Quality (MQE) and semi-guided interviews will complete the collection of qualitative data. The expected results concern the identification of the barriers or facilitators the sickle cell patients might face in their social participation, whether they are affected or not by neurological disorders.

Detailed description

Sickle cell anaemia, which is the most frequent genetic disease in France, requires an early and optimal care to reduce its morbidity and mortality. Children with sickle cell anaemia who are significantly anaemic may present neurological complications including stroke with or without clinical signs. A major risk associated to these strokes is the impairment of the general intellectual ability and learning ability, essentially resulting from neuropsychological disorders affecting intellectual functioning, executive and attentional functions. Although the negative impact of sickle cell anemia on the quality of life of the affected children and adolescents is well documented, no study has been focused on the role played by the neurocognitive disorders on their social participation. The objective of this project is the assessment of the influence of neurocognitive disorders in the social participation of children and adolescent with sickle cell anemia (6 to 16 years old), followed in Guadeloupe. This project will promote the development of transdisciplinary analyses. Neuropsychological disorders will be explored with the usual appropriate tests done by psychologists and neuropsychologists regularly involved in the management of sickle cell disease affected children. For the social sciences' component, various methods will be used: Measure of the Life habits (MHAVIE), Measure of Environmental Quality (MQE) and semi-guided interviews will complete the collection of qualitative data. The expected results concern the identification of the barriers or facilitators the sickle cell patients might face in their social participation, whether they are affected or not by neurological disorders

Interventions

OTHERMeasure of the Life habits (MHAVIE)

Life habits include daily activities and social in 6 groups. Environmental factors include social (9 different subgroups) and physical factors (7 different subgroups). Personal factors are person related parameters (gender, age, sociocultural ethnic, skills, deficiencies factors,…).

Sponsors

Université des Antilles, LAboratoire ACTES
CollaboratorUNKNOWN
Centre Hospitalier Universitaire de la Guadeloupe
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Sickle cell anemia * Age between 6 and 16 years inccuded, attending the centre of reference for sickle cell disease in Guadeloupe * Informed consent * Medical insurance

Exclusion criteria

* Other sickle cell syndrome other than SS or Sb-thal * Less than 6 years old or older than 16 * Attending other sickle cell departments * No medical insurance

Design outcomes

Primary

MeasureTime frameDescription
MHAVIE-ChildrenInclusionAssessment of Life Habits-LIFE-H
MQEInclusionMeasure of Environmental Quality (MQE)

Countries

Guadeloupe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026